24 results for “legislation”
The Last Prisoner Project is encouraging US politicians to back the new Marijuana Opportunity Reinvestment and Expungement Act (MORE act). The group of cannabis industry leaders, social justice advocates and […]
Over three quarters of the UK population have welcomed last year’s law change allowing for cannabis to be prescribed as a medicine, research reveals.
The CBD manufacturer has received a draft positive scientific opinion from EFSA on its Novel Food application.
Germany has voted to ban medical cannabis flower from its statutory health insurance scheme.
Inspectors found breaches in care, governance, and oversight at a private medical cannabis clinic.
Less than 100 patients have been approved for medical cannabis treatment under the MCAP scheme.
After two years of Germany’s Cannabis Act (CanG), the most comprehensive analysis of its impact to date has been published.
A new campaign is calling for urgent regulatory changes to how medical cannabis is prescribed to psychiatric patients in the UK.
Early findings on the impact of the partial legalisation of cannabis suggest no short-term spike in consumption or drug-driving.
Patients and healthcare professionals have responded to recent media coverage about medical cannabis in the UK.
Last week, the first official guidance on medical cannabis for police officers in England and Wales was made public.
The team at Prohibition Partners shares how they think things will shape up for medical cannabis in 2026.
The study found that 88% of participating officers knew little or nothing about the regulations before taking part in the training.
Spain’s Council of Ministers has approved a Royal Decree regulating the medicinal use of cannabis preparations in hospital settings.
New guidelines aim to bring more clarity and consistency to the practice of prescribing cannabis-based medicines in the UK.
Portugal hosted its seventh international conference on medical cannabis (PTMC) in central Lisbon last week.
The UK’s long-running project to regulate CBD (cannabidiol) products has taken another major step forward, seeing thousands of products make it to the final phase of the novel foods approval […]
Dr Sue Clenton, Medical Director at Releaf explores the role that clinics can play in recruiting and training the next generation of medical cannabis professionals.
The issues raised have led to calls for a multi-agency review and clarification of the regulations.
Findings from The European Cannabis Report: 10th Edition reflect a decade of immense change across European cannabis markets.
A Freedom of Information request has established that the NHS will publish data from its ‘registry’ by the ‘end of the year’.
Campaigners are urging lawmakers to consider the challenges facing people who rely on access for medical purposes.
Cannabis Europa panellist and Grow Group’s Managing Director, Pierre van Weperen, on the current state of play, and the future of cannabis-based medicine in the UK.
The Advisory Council on the Misuse of Drugs (ACMD) will carry out a formal review of the regulatory framework around cannabis-based medicinal products.
